- Global Pharma News & Resources

Innovative Trials suspends services in Russia in response to Ukraine war

Innovative Trials suspends services in Russia in response to Ukraine war


In response to the ongoing conflict in Ukraine, Innovative Trials, a global clinical trial patient recruitment company with headquarters in the UK, has suspended all services within Russia and implemented a package of measures to support those affected, including its own staff.


Kate Shaw, founder and Chief Executive Officer of Innovative Trials, said: “As an organisation working in an industry focused on improving lives through better health, we condemn violence in all of its forms. 


“We stand with the people of Ukraine and are doing all we can to help those affected by this conflict. We remain dedicated to supporting our global team, which includes providing financial, emotional and practical support to those who remain in Ukraine, and have suspended our services within Russia. 


“We can’t begin to imagine how it must feel to flee your country in the wake of such terror, but we passionately want to help. We are committed to matching donations that our employees make to the Disasters Emergency Committee humanitarian appeal and are using our networks to identify qualified Ukrainians fleeing the war zone who may be a good fit for vacancies within our company.


“We hope a resolution to this conflict can be found quickly to avert any further tragedy. Everyone deserves to live in peace and without fear.”

Editor Details

Last Updated: 01-Apr-2022